Transepithelial transport of rosuvastatin and effect of ursolic acid on its transport in Caco-2 monolayers

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 37, Issue 3, 2012, Pages 225-231

  Hua, Wen Jin ^a   Fang, Hu Jin ^a   Hua, Wei Xiao ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Caco 2 cell monolayers; Rosuvastatin; Ursolic acid

Indexed keywords

1,2,3,4,6,7,12,12A OCTAHYDRO 6 ISOBUTYL 9 METHOXY 1,4 DIOXOPYRAZINO[1',2':1,6]PYRIDO[3,4 B]INDOLE 3 PROPANOIC ACID TERT BUTYL ESTER; BREAST CANCER RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; ROSUVASTATIN; TALINOLOL; URSOLIC ACID;

ACTIVE TRANSPORT; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEOPLASM PROTEINS; PYRIMIDINES; SULFONAMIDES; TRITERPENES;

EID: 84871335784     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-012-0094-9     Document Type: Article

References (19)

1. Artursson P, Palm K, Luthman K (2001) Caco-2 monolayers inexperimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 46:27-43
2. Chapman MJ, Taggart FM (2002) Optimizing the pharmacology of statins: characteristics of rosuvastatin. Atheroscler Suppl 2:33-36 discussion 36-37
3. Chunshan G, Amanda O, Rathnam C, Bruno H (2010) Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1-8
4. Cooper KJ, Martin PD, Dane AL, Warwick MJ, Raza A, Schneck DW (2003) Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. Br J Clin Pharmacol 55(1):94-99
5. Huayi R (2009) Inhibition of the function of p-glycoprotein by ursolic acid. Central South Pharm 7(7):493-496
6. Itagaki S, Kobayashi Y, Otsuka Y, Kubo S, Kobayashi M, Hirano T, Iseki K (2005) Food-drug interaction between ferulic acid and nateglinide involving the fluorescein/H? cotransport system. J Agric Food Chem 53:2499-2502
7. Li J, Volpe DA, Wang Y, Zhang W, Bode C, Owen A, Hidalgo IJ (2011) Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs. Drug Metab Dispos 39(7):1196-1202
8. Liyue Hu, Yi W, Scott G (2006) ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein. Drug Metab Dispos 34:738-742
9. Martin PD, Warwick MJ, Dane AL, Brindley C, Short T (2003a) Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. Clin Ther 25:2553-2563
10. Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, Lenz E (2003b) Metabolism, excretion and pharmacokinetics of rosuvastatin in healthy adult volunteers. Clin Ther 25:2822-2835
11. Nobuhiro N, Kohji N, Tomochika U, Hidenari H, Kikuo I (2004) Transepithelial permeation of tolbutamide across the human intestinal cell line, Caco-2. DrugMetab Pharmacokin 19(1):48-54
12. Paoletti R, Fahmy M, Mahla G, Mizan J, Southworth H (2001) Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double blind study. J Cardiovasc Risk 8:383-890
13. Satoshi K, Kazuya M, Yi W, Yuichi S (2008) Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 36(10):2014-2023
14. Wen JH, Xiong YQ (2011) The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. Eur J Drug Metab Pharmacokinet 36:205-211
15. Wen T, Jinjian L, Mingqing H, Yingbo L, Meiwan C, Guosheng W, Jian G, Zhangfeng Z, Zengtao X, Yuanye D, Jiajie G, Xiuping C, Yitao W (2011a) Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med 6:1-27
16. Wen T, Jinjian L, Mingqing H, Yingbo L, Meiwan C, Guosheng W, Jian G, Zhangfeng Z, Zengtao X, Yuanye D, Jiajie G, Xiuping C, Yitao W (2011b) Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med 6:1-27
17. Xia Y, Wei G, Si D, Liu C (2011) Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 15 879(2):219-224
18. Xingang Z, Xuelian Z, Guo M, Junkai Y, Honghai W, Qing Y (2011) Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. J Pharm Pharmaceut Sci 14(3):325-335. http://www.cspsCanada.org
19. Yoshikazu G, Shirou I, Shinichiro U, Masaki K, Takeshi H, Ken I, Koji T (2005) Transepithelial transport of telmisartan in Caco-2 monolayers. Biol Pharm Bull 28(12):2235-2239